Perceptive Capital Solutions Corp (PCSC) is a SPAC formed in 2024 with a $86.25 million trust account, targeting life sciences and medical technology companies in North America and Europe. It entered a business combination agreement with Freenome Holdings in late 2025, aiming for consummation in 2026, but faces liquidity constraints and shareholder redemption dynamics that complicate deal execution. The company also confronts external risks including international trade policy shifts that could affect target viability and capital raising. Its management team’s sector expertise provides a credible platform, yet successful deal completion and post-merger integration remain key watchpoints.